sábado, 7 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

AGNC (AGNC) Q3 2024 Earnings Call Transcript

View original at finance.yahoo.com
AGNC (AGNC) Q3 2024 Earnings Call Transcript Image source: The Motley Fool. Date Oct. 22, 2024 • 8:30 a.m…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Net spread and dollar roll income has been well over the dividend for a couple of years and is not a driver of dividend policy

    80% confidence
  • Agency MBS supply is expected to increase modestly with lower rates

    80% confidence
  • Recent refinancing wave was short-lived and response was less aggressive than during COVID for the same incentive

    80% confidence
  • The likely scenario is that primary mortgage rates stay above 6.5% for an extended period

    80% confidence
  • 68% unencumbered capacity gives ability to raise leverage once spread range confidence and election volatility pass

    80% confidence
  • Basel III endgame resolution is expected to be delayed from late Q3

    80% confidence
  • Consumer credit is divided with lower income pressure but no significant distress

    80% confidence
  • Federal Reserve projects 250 basis points decline in fed funds rate by end of 2026

    80% confidence
  • Election volatility is expected through November with defensive positioning via delta hedging

    80% confidence
  • Servicing capacity is not an issue for mortgage refinancing

    80% confidence
  • The investment environment is promising and durable, characterized by mortgage spreads materially wider than historical norms, declining interest-rate volatility, and emerging accommodative monetary policy

    80% confidence
  • Production coupons offer the best long-run risk-adjusted returns

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com
AGNC (AGNC) Q3 2024 Earnings Call Transcript — Source | Via News | es.VIA.NEWS